COMMUNIQUÉS West-GlobeNewswire
-
Interim Report January-September 2018
23/10/2018 - 08:00 -
GENFIT: Third quarter 2018 financial information
23/10/2018 - 07:47 -
GENFIT : information financière du troisième trimestre 2018
23/10/2018 - 07:47 -
Alcon to develop SMART Suite digital health platform for cataract surgery
23/10/2018 - 07:16 -
Idorsia financial results for the first nine months of 2018
23/10/2018 - 07:03 -
Idorsia announces that Simon Jose is to join the company as Chief Commercial Officer
23/10/2018 - 07:01 -
Innate Pharma strengthens and expands its oncology development collaboration with AstraZeneca
23/10/2018 - 07:01 -
Innate Pharma renforce et étend sa collaboration de développement en oncologie avec AstraZeneca
23/10/2018 - 07:01 -
MDxHealth Provides Business Update for the first nine months of 2018
23/10/2018 - 07:01 -
MDxHealth (R): MDxHealth publie son rapport d'activités intermédiaire relatif aux neuf premiers mois de 2018
23/10/2018 - 07:01 -
UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus
23/10/2018 - 07:00 -
IntelGenx Completes US$12 Million Equity Offering
23/10/2018 - 00:53 -
Novartis announces Lancet publication of pioneering study in migraine prevention showing efficacy of Aimovig® where other treatments have failed
23/10/2018 - 00:30 -
Chembio Announces Proposed Public Offering of Common Stock
22/10/2018 - 23:27 -
INSYS Therapeutics to Report Third Quarter 2018 Results on Nov. 5
22/10/2018 - 23:00 -
National Research Corporation to Broadcast its 2018 Third Quarter Conference Call Live on the Internet
22/10/2018 - 23:00 -
ContraFect to Participate in World Antimicrobial Resistance Congress 2018
22/10/2018 - 23:00 -
MacroGenics Announces Participation in Three Investor Conferences
22/10/2018 - 23:00 -
NanoVibronix to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
22/10/2018 - 22:47
Pages